Insider trading · Q3 2026 · CIK 874716

Idexx Laboratories Inc /De (IDXX) insider trading.

In Q3 2026, insiders at Idexx Laboratories Inc /De reported 5 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $1.2M.

Transactions
5
Purchases (P)
0
Sales (S)
1
Net shares, P minus S
-2,203
Insiders
3
Last filed
2026-09-09

Insiders

InsiderRelationshipTransactionsBuysSales
Kingsley Lawrence DDirector201
Emerson AndrewOfficer · EVP, CFO and Treasurer200
Hooley Joseph LDirector100

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-04Kingsley Lawrence DM (A)2,203$114.1711,771Form 4
2026-09-04Kingsley Lawrence DS (D)2,203$532.089,568Form 4
2026-08-20Emerson AndrewF (D)86$04,421Form 4
2026-08-20Emerson AndrewM (A)265$178.264,507Form 4
2026-07-30Hooley Joseph LA (A)49$558.8325Form 4

Transaction codes in this quarter

Get IDXX insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=874716&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · IDXX company page · Idexx Laboratories Inc /De on SEC.gov

Questions

Are insiders buying or selling Idexx Laboratories Inc /De (IDXX)?

In Q3 2026, insiders at Idexx Laboratories Inc /De reported 5 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $1.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Idexx Laboratories Inc /De insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/idxx.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.